Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment

Torsten Schröder, Klaus J. Schmidt, Vera Olsen, Steffen Möller, Tilo Mackenroth, Christian Sina, Hendrik Lehnert, Klaus Fellermann, Jürgen Büning*

*Corresponding author for this work
12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences